DYMISTA
Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Oct 2025)
What this means for you
This application is over — abandoned 15 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97637153
- Mark type
- Design + words
- Filed
- 18 Oct 2022
- Published for opposition
- 19 Sept 2023
- Abandoned
- 15 Oct 2025
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of allergies
Owner
- Meda Pharmaceuticals Inc., Canonsburg, PA, US
- Meda Pharmaceuticals Inc., Canonsburg, PA, US
Prosecution history
- 15 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 15 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 07 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Nov 2024 — SOU EXTENSION 2 GRANTED
- 07 Nov 2024 — SOU EXTENSION 2 FILED
- 07 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 15 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 May 2024 — SOU EXTENSION 1 GRANTED
- 14 May 2024 — SOU EXTENSION 1 FILED
- 14 May 2024 — SOU TEAS EXTENSION RECEIVED
- 14 Nov 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Sept 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Sept 2023 — PUBLISHED FOR OPPOSITION
- 30 Aug 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Aug 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER